# Crocs, Inc.: financial statements, quarterly

CROX · Nasdaq · CIK 1334036 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/crox.md) · [Financials](/companies/crox/financials.md) · [Filings](/companies/crox/filings.md) · [Insiders](/companies/crox/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/crox/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [960 d](/filings/0001334036-26-000006.md) | [939](/filings/0001334036-25-000054.md) | [1,112](/filings/0001334036-25-000085.md) | [1,062](/filings/0001334036-25-000101.md) | [990 d](/filings/0001334036-26-000006.md) | [937](/filings/0001334036-26-000032.md) | [1,149](/filings/0001334036-26-000052.md) | [996](/filings/0001334036-26-000060.md) | [958 d](/filings/0001334036-26-000006.md) | [921](/filings/0001334036-26-000032.md) | [1,179](/filings/0001334036-26-000052.md) | [1,043](/filings/0001334036-26-000060.md) |
| Cost of revenue | $m | [429 d](/filings/0001334036-26-000006.md) | [417](/filings/0001334036-25-000054.md) | [430](/filings/0001334036-25-000085.md) | [429](/filings/0001334036-25-000101.md) | [417 d](/filings/0001334036-26-000006.md) | [396](/filings/0001334036-26-000032.md) | [441](/filings/0001334036-26-000052.md) | [413](/filings/0001334036-26-000060.md) | [434 d](/filings/0001334036-26-000006.md) | [399](/filings/0001334036-26-000032.md) | [479](/filings/0001334036-26-000052.md) | [353](/filings/0001334036-26-000060.md) |
| Gross profit | $m | [531 d](/filings/0001334036-26-000006.md) | [522](/filings/0001334036-25-000054.md) | [682](/filings/0001334036-25-000085.md) | [633](/filings/0001334036-25-000101.md) | [573 d](/filings/0001334036-26-000006.md) | [542](/filings/0001334036-26-000032.md) | [709](/filings/0001334036-26-000052.md) | [583](/filings/0001334036-26-000060.md) | [524 d](/filings/0001334036-26-000006.md) | [523](/filings/0001334036-26-000032.md) | [701](/filings/0001334036-26-000052.md) | [690](/filings/0001334036-26-000060.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [312 d](/filings/0001334036-26-000006.md) | [296](/filings/0001334036-25-000054.md) | [356](/filings/0001334036-25-000085.md) | [364](/filings/0001334036-25-000101.md) | [373 d](/filings/0001334036-26-000006.md) | [319](/filings/0001334036-26-000032.md) | [398](/filings/0001334036-26-000052.md) | [375](/filings/0001334036-26-000060.md) | [377 d](/filings/0001334036-26-000006.md) | [322](/filings/0001334036-26-000032.md) | [415](/filings/0001334036-26-000052.md) | [398](/filings/0001334036-26-000060.md) |
| Operating income | $m | [210 d](/filings/0001334036-26-000006.md) | [226](/filings/0001334036-25-000054.md) | [326](/filings/0001334036-25-000085.md) | [270](/filings/0001334036-25-000101.md) | [200 d](/filings/0001334036-26-000006.md) | [223](/filings/0001334036-26-000032.md) | [(428)](/filings/0001334036-26-000052.md) | [208](/filings/0001334036-26-000060.md) | [146 d](/filings/0001334036-26-000006.md) | [201](/filings/0001334036-26-000032.md) | [286](/filings/0001334036-26-000052.md) | [292](/filings/0001334036-26-000060.md) |
| Interest expense | $m | [36.4 d](/filings/0001334036-24-000025.md) | [30.6](/filings/0001334036-24-000096.md) | [29.2](/filings/0001334036-25-000085.md) | [26.2](/filings/0001334036-25-000101.md) | [23.3 d](/filings/0001334036-26-000006.md) | [22.8](/filings/0001334036-26-000032.md) | [22.5](/filings/0001334036-26-000052.md) | [21.7](/filings/0001334036-26-000060.md) | [21.3 d](/filings/0001334036-26-000006.md) | [20.5](/filings/0001334036-26-000032.md) | [19.9](/filings/0001334036-26-000052.md) | [19.1](/filings/0001334036-26-000060.md) |
| Income tax | $m | [(79.7) d](/filings/0001334036-26-000006.md) | [41.6](/filings/0001334036-25-000054.md) | [67.5](/filings/0001334036-25-000085.md) | [45.1](/filings/0001334036-25-000101.md) | [(194) d](/filings/0001334036-26-000006.md) | [44.8](/filings/0001334036-26-000032.md) | [43.7](/filings/0001334036-26-000052.md) | [43.6](/filings/0001334036-26-000060.md) | [22.1 d](/filings/0001334036-26-000006.md) | [41.3](/filings/0001334036-26-000032.md) | [59.0](/filings/0001334036-26-000052.md) | [60.7](/filings/0001334036-26-000060.md) |
| Net income | $m | [254 d](/filings/0001334036-26-000006.md) | [152](/filings/0001334036-25-000054.md) | [229](/filings/0001334036-25-000085.md) | [200](/filings/0001334036-25-000101.md) | [369 d](/filings/0001334036-26-000006.md) | [160](/filings/0001334036-26-000032.md) | [(492)](/filings/0001334036-26-000052.md) | [146](/filings/0001334036-26-000060.md) | [105 d](/filings/0001334036-26-000006.md) | [138](/filings/0001334036-26-000032.md) | [205](/filings/0001334036-26-000052.md) | [217](/filings/0001334036-26-000060.md) |
| Diluted EPS | $ per share | not reported | [2.50](/filings/0001334036-25-000054.md) | [3.77](/filings/0001334036-25-000085.md) | [3.36](/filings/0001334036-25-000101.md) | not reported | [2.83](/filings/0001334036-26-000032.md) | [(8.82)](/filings/0001334036-26-000052.md) | [2.70](/filings/0001334036-26-000060.md) | not reported | [2.71](/filings/0001334036-26-000032.md) | [4.13](/filings/0001334036-26-000052.md) | [4.52](/filings/0001334036-26-000060.md) |
| Basic EPS | $ per share | not reported | [2.52](/filings/0001334036-25-000054.md) | [3.79](/filings/0001334036-25-000085.md) | [3.38](/filings/0001334036-25-000101.md) | not reported | [2.85](/filings/0001334036-26-000032.md) | [(8.82)](/filings/0001334036-26-000052.md) | [2.72](/filings/0001334036-26-000060.md) | not reported | [2.74](/filings/0001334036-26-000032.md) | [4.17](/filings/0001334036-26-000052.md) | [4.57](/filings/0001334036-26-000060.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [149](/filings/0001334036-25-000009.md) | [159](/filings/0001334036-24-000096.md) | [168](/filings/0001334036-24-000140.md) | [186](/filings/0001334036-24-000159.md) | [180](/filings/0001334036-26-000006.md) | [166](/filings/0001334036-25-000054.md) | [201](/filings/0001334036-25-000085.md) | [154](/filings/0001334036-25-000101.md) | [130](/filings/0001334036-26-000060.md) | [131](/filings/0001334036-26-000032.md) | [170](/filings/0001334036-26-000052.md) | [163](/filings/0001334036-26-000060.md) |
| Current assets | $m | [911](/filings/0001334036-25-000009.md) | [1,106](/filings/0001334036-24-000096.md) | [1,027](/filings/0001334036-24-000140.md) | [990](/filings/0001334036-24-000159.md) | [872](/filings/0001334036-26-000006.md) | [1,074](/filings/0001334036-25-000054.md) | [1,102](/filings/0001334036-25-000085.md) | [971](/filings/0001334036-25-000101.md) | [886](/filings/0001334036-26-000060.md) | [1,065](/filings/0001334036-26-000032.md) | [1,085](/filings/0001334036-26-000052.md) | [1,028](/filings/0001334036-26-000060.md) |
| Total assets | $m | [4,644](/filings/0001334036-25-000009.md) | [4,796](/filings/0001334036-24-000096.md) | [4,720](/filings/0001334036-24-000140.md) | [4,713](/filings/0001334036-24-000159.md) | [4,812](/filings/0001334036-26-000006.md) | [5,066](/filings/0001334036-25-000054.md) | [4,451](/filings/0001334036-25-000085.md) | [4,300](/filings/0001334036-25-000101.md) | [4,175](/filings/0001334036-26-000060.md) | [4,343](/filings/0001334036-26-000032.md) | [4,356](/filings/0001334036-26-000052.md) | [4,281](/filings/0001334036-26-000060.md) |
| Current liabilities | $m | [698](/filings/0001334036-25-000009.md) | [629](/filings/0001334036-24-000096.md) | [686](/filings/0001334036-24-000140.md) | [693](/filings/0001334036-24-000159.md) | [740](/filings/0001334036-26-000006.md) | [705](/filings/0001334036-25-000054.md) | [715](/filings/0001334036-25-000085.md) | [692](/filings/0001334036-25-000101.md) | [700](/filings/0001334036-26-000060.md) | [640](/filings/0001334036-26-000032.md) | [728](/filings/0001334036-26-000052.md) | [714](/filings/0001334036-26-000060.md) |
| Total liabilities | $m | [3,190](/filings/0001334036-25-000009.md) | [3,199](/filings/0001334036-24-000096.md) | [3,067](/filings/0001334036-24-000140.md) | [2,988](/filings/0001334036-24-000159.md) | [2,976](/filings/0001334036-26-000006.md) | [3,097](/filings/0001334036-25-000054.md) | [3,029](/filings/0001334036-25-000085.md) | [2,937](/filings/0001334036-25-000101.md) | [2,881](/filings/0001334036-26-000060.md) | [2,916](/filings/0001334036-26-000032.md) | [2,972](/filings/0001334036-26-000052.md) | [2,936](/filings/0001334036-26-000060.md) |
| Long-term debt | $m | [1,641](/filings/0001334036-25-000009.md) | [1,727](/filings/0001334036-24-000096.md) | [1,530](/filings/0001334036-24-000140.md) | [1,422](/filings/0001334036-24-000159.md) | [1,349](/filings/0001334036-26-000006.md) | [1,482](/filings/0001334036-25-000054.md) | [1,379](/filings/0001334036-25-000085.md) | [1,318](/filings/0001334036-25-000101.md) | [1,231](/filings/0001334036-26-000060.md) | [1,330](/filings/0001334036-26-000032.md) | [1,308](/filings/0001334036-26-000052.md) | [1,289](/filings/0001334036-26-000060.md) |
| Current portion of debt | $m | [23.3](/filings/0001334036-25-000009.md) | [0.0](/filings/0001334036-24-000096.md) | [0.0](/filings/0001334036-24-000140.md) | [0.0](/filings/0001334036-24-000159.md) | [0.0](/filings/0001334036-25-000009.md) | not reported | not reported | not reported | [0.0](/filings/0001334036-26-000032.md) | [5.6](/filings/0001334036-26-000032.md) | not reported | not reported |
| Shareholders' equity | $m | [1,454](/filings/0001334036-26-000006.md) | [1,597](/filings/0001334036-25-000085.md) | [1,653](/filings/0001334036-25-000101.md) | [1,725](/filings/0001334036-25-000101.md) | [1,836](/filings/0001334036-26-000060.md) | [1,970](/filings/0001334036-26-000052.md) | [1,421](/filings/0001334036-26-000060.md) | [1,363](/filings/0001334036-26-000060.md) | [1,293](/filings/0001334036-26-000060.md) | [1,427](/filings/0001334036-26-000052.md) | [1,385](/filings/0001334036-26-000060.md) | [1,345](/filings/0001334036-26-000060.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [350 d](/filings/0001334036-26-000006.md) | [(27.6)](/filings/0001334036-25-000054.md) | [401 d](/filings/0001334036-25-000085.md) | [297 d](/filings/0001334036-25-000101.md) | [322 d](/filings/0001334036-26-000006.md) | [(67.2)](/filings/0001334036-26-000032.md) | [286 d](/filings/0001334036-26-000052.md) | [239 d](/filings/0001334036-26-000060.md) | [253 d](/filings/0001334036-26-000006.md) | [(80.9)](/filings/0001334036-26-000032.md) | [352 d](/filings/0001334036-26-000052.md) | [290 d](/filings/0001334036-26-000060.md) |
| Capital expenditure | $m | [29.2 d](/filings/0001334036-26-000006.md) | [15.8](/filings/0001334036-25-000054.md) | [17.1 d](/filings/0001334036-25-000085.md) | [18.1 d](/filings/0001334036-25-000101.md) | [18.5 d](/filings/0001334036-26-000006.md) | [15.4](/filings/0001334036-26-000032.md) | [16.6 d](/filings/0001334036-26-000052.md) | [13.2 d](/filings/0001334036-26-000060.md) | [6.1 d](/filings/0001334036-26-000006.md) | [18.0](/filings/0001334036-26-000032.md) | [20.7 d](/filings/0001334036-26-000052.md) | [14.9 d](/filings/0001334036-26-000060.md) |
| Share repurchases | $m | [25.0 d](/filings/0001334036-26-000006.md) | [0.0](/filings/0001334036-25-000054.md) | [175 d](/filings/0001334036-25-000085.md) | [151 d](/filings/0001334036-25-000101.md) | [226 d](/filings/0001334036-26-000006.md) | [60.9](/filings/0001334036-26-000032.md) | [133 d](/filings/0001334036-26-000052.md) | [208 d](/filings/0001334036-26-000060.md) | [180 d](/filings/0001334036-26-000006.md) | [0.0](/filings/0001334036-26-000032.md) | [256 d](/filings/0001334036-26-000052.md) | [250 d](/filings/0001334036-26-000060.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [62.6](/filings/0001334036-24-000096.md) | [62.6](/filings/0001334036-24-000140.md) | [61.6](/filings/0001334036-24-000159.md) | [61.1](/filings/0001334036-25-000054.md) | [60.8](/filings/0001334036-25-000085.md) | [59.5](/filings/0001334036-25-000101.md) | [56.5](/filings/0001334036-26-000032.md) | [55.8](/filings/0001334036-26-000052.md) | [54.0](/filings/0001334036-26-000060.md) | [50.7](/filings/0001334036-26-000032.md) | [49.6](/filings/0001334036-26-000052.md) | [48.0](/filings/0001334036-26-000060.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 45,725,039 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0001334036-26-000060.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 12:12 ET. No prices; not investment advice.